Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? Yes
Write-up: Disseminated intravascular coagulation; Multiple organ failure; Cytokine release syndrome; This is a spontaneous report from a non-contactable physician downloaded from the Regulatory Authority (RA)-WEB DE-PEI-202100116970. A 50-years-old female patient received bnt162b2 (COMIRNATY, Solution for injection) (mRNA TOZINAMERAN), dose 2 intramuscular on 07Jun2021 (Batch/Lot Number: FA5833) as DOSE 2, 0.3 ML SINGLE for covid-19 immunization. The patient medical history was not reported. There were no concomitant medications. Previously patient received bnt162b2 (COMIRNATY), dose 1 intramuscular on 07Jun2021 (Batch/Lot Number: not reported) as DOSE 1, 0.3 ML SINGLE for covid-19 immunization. On 07Jun2021 the patient experienced cytokine release syndrome, disseminated intravascular coagulation and multiple organ failure. Lab investigations includes massive cytokine increase. The patient died on an unspecified date. It was not reported if an autopsy was performed. This report is serious - death, hospitalization, life threatening. Outcome was reported as fatal. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: Cytokine release syndrome; Disseminated intravascular coagulation; Multiple organ failure
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166